The stock has exhibited a strong uptrend over the past six months, with the price rising from $23.50 on October 2, 2025, to $29.40 on March 31, 2026, representing a 25.1% gain. This performance significantly outpaced the broader market, as indicated by a 6-month relative strength of +27.93. Short-term performance has been volatile, with a 1-month decline of 8.67% but a robust 3-month gain of 34.12%. The stock's 1-year performance is exceptionally strong, up 193.12%, far exceeding the S&P 500's 15.93% gain. The current price of $29.40 is near the upper end of its 52-week range of $8.65 to $33.49, trading approximately 12% below the yearly high. The stock's beta of 0.86 suggests it has been less volatile than the overall market during this period.

Revenue and profitability have shown significant improvement. For Q4 2025, revenue was $529.7 million, representing a 63.9% year-over-year growth from Q4 2024. The net income margin for the latest quarter was a robust 34.8%, a substantial recovery from the 1.7% margin in the year-ago period, driven by higher gold prices and operational performance. The company maintains a strong financial position with a low debt-to-equity ratio of 0.12 and a healthy current ratio of 2.08. Free cash flow for the trailing twelve months was $348.4 million, indicating solid cash generation. Operational efficiency metrics are positive, with a return on equity (ROE) of 11.5% and a return on assets (ROA) of 5.93%, reflecting effective use of capital and assets.